Trauma Doesn't Stay in the Past. But Your Brain Can Learn Something New

You know intellectually that the event is over. You know you are safe. And yet your nervous system keeps behaving as though you're still in it. The flashbacks arrive without warning. Sleep is either impossible or filled with nightmares. Certain sounds, smells, or situations that mean nothing to other people pull you back instantly, completely, against your will. You have tried to talk about it. Maybe you have tried medication. Maybe you have made real progress in therapy, and then hit a wall that no amount of talking seems to move.

That wall is not a personal failure. It is a neurological reality. PTSD is not simply a psychological wound, it is a measurable change in how the brain processes threat, memory, and fear. And the treatments that have existed for decades, SSRIs and standard talk therapy, work for some people but leave a substantial number of others with persistent, disabling symptoms.

IV ketamine is one of the most promising developments in PTSD treatment in a generation. At Ketamine Wellness Infusions PA, located minutes from Lower Merion Township in Bala Cynwyd, we offer IV ketamine infusions specifically for people living with PTSD that has not responded adequately to conventional care.

Our founder Jill Gabay is a senior CRNA with more than 30 years of anesthesia experience, a member of the American Society of Ketamine Physicians, Psychotherapists and Practitioners, and personally present for every infusion we administer.

We hold a 5.0 Google rating. Patients describe our clinic as the place where things finally started to shift.

Schedule a consultation and find out if IV ketamine is the right PTSD treatment for you.

Why PTSD Is So Resistant to Conventional Treatment

PTSD affects roughly 8 million adults in the United States at any given time. Despite how common it is, the pharmacological options approved by the FDA for its treatment remain limited to just two medications: the SSRIs sertraline and paroxetine. Both work on the serotonin system. And according to clinical research published in SAGE Journals, up to 60% of patients with PTSD do not respond to SSRIs, fewer than 30% achieve full remission, and many experience significant side effects before seeing any benefit at all.That is not a marginal treatment gap. That is a majority of people with PTSD living without adequate relief from the only FDA-approved pharmacological options available to them.

Talk therapy, particularly trauma-focused modalities like prolonged exposure therapy and EMDR, produces meaningful results for many patients. But access to qualified trauma therapists is limited, the process is demanding, and a significant percentage of patients either do not respond fully or disengage before completing treatment. The result, as researchers have called it, is a genuine PTSD pharmacotherapy crisis.

What PTSD needs is a treatment that targets the underlying neurobiology of the condition at a different level. That is exactly where IV ketamine enters the picture.

How IV Ketamine Treats PTSD at the Neurological Level

PTSD is not simply a disorder of memory or thought. It is a disorder of how the brain has reorganized itself in response to overwhelming experience.

Trauma dysregulates glutamatergic signaling, the brain's primary excitatory neurotransmitter system, in ways that maintain fear responses, impair extinction learning, and lock traumatic memories into a state of heightened accessibility. The brain, in trying to protect you from future harm, has essentially gotten stuck in an alarm state. Every time a trauma-related stimulus appears, the alarm fires. Standard antidepressants do not address this glutamate dysregulation. Ketamine does.

As an NMDA receptor antagonist, ketamine directly targets the glutamate system. By blocking NMDA receptors, it triggers a cascade that promotes synaptogenesis, the rapid growth of new synaptic connections in brain regions damaged by chronic stress and trauma. It also creates a neurological window during which traumatic memories can be reprocessed and reconsolidated in a less rigid, less fear-dominated form. Research published in Neuropsychopharmacology found that a single ketamine infusion followed by brief trauma-focused psychotherapy produced long-term structural and functional neural changes in PTSD patients, including measurable improvements in how the brain processed and stored traumatic memory.

A landmark randomized clinical trial conducted at the Icahn School of Medicine at Mount Sinai found that a single IV ketamine infusion was associated with rapid, significant reduction in PTSD symptom severity within 24 hours, compared to an active placebo control. A subsequent meta-analysis published in 2024 analyzing six randomized controlled trials found that ketamine significantly reduced scores on validated PTSD measures, the Clinician-Administered PTSD Scale and the PTSD Checklist, at day one, and at weeks one, two, and four following treatment.

A 2024 retrospective study examining 117 PTSD patients treated with IV ketamine found that 75% achieved clinically meaningful improvement on validated PTSD measures, and 62% experienced complete remission of symptoms.

These are not preliminary signals. They are consistent findings across multiple high-quality trials conducted at leading research institutions.

What Treatment Looks Like at Our Clinic

Your treatment begins with a thorough consultation. Jill Gabay reviews your trauma history, current symptoms, prior treatments, and any medications you are taking. The goal is to understand your full clinical picture before recommending a course of action. If IV ketamine is not the right fit, she will tell you honestly.

The standard initial course is six IV ketamine infusions typically completed over two to three weeks. Each session lasts approximately 40 to 60 minutes and takes place in a calm, quiet room designed to support the kind of internal experience that makes ketamine most effective for PTSD. Blankets, eye masks, and essential oil diffusers are provided. Jill or a member of our care team is present throughout every session, monitoring your vital signs and ensuring your comfort.

Many patients with PTSD find value in pairing their infusion series with existing therapeutic work. The neuroplasticity window that ketamine opens in the days following each infusion is a genuine opportunity to process trauma more effectively with a therapist. If you are currently working with a therapist, we are glad to coordinate with them. If you are not, we can speak to options.

After your infusion series, Jill conducts personal follow-up check-ins to assess your response, support integration of the experience, and determine whether maintenance infusions are appropriate for your ongoing care.

Types of Trauma and PTSD We Treat

PTSD does not have a single face. It develops across a wide range of experiences, and the people who live with it come from every background, every profession, and every walk of life.

We treat PTSD arising from combat and military service, sexual assault and abuse, childhood trauma and adverse early experiences, accidents and medical trauma, sudden loss and grief, workplace trauma, and community or mass violence. We also treat complex PTSD, the form that develops from prolonged, repeated traumatic exposure rather than a single incident, which tends to be particularly resistant to standard treatment approaches.

What all of these presentations share is the same underlying neurobiological disruption, and ketamine addresses that disruption at its root.

Why Lower Merion Township Patients Choose Our Clinic

Our clinic at 146 Montgomery Ave, Suite 202 in Bala Cynwyd sits directly inside Lower Merion Township, accessible from Ardmore, Wynnewood, Narberth, Penn Valley, Bryn Mawr, and throughout the Main Line without the complexity of navigating into Philadelphia.

What makes this clinic different is the depth of clinical experience Jill Gabay brings to every infusion. She has spent more than 30 years in anesthesia, mastering the pharmacology and clinical management that IV ketamine requires when administered at psychiatric dosing levels for conditions as serious and complex as PTSD. Fellow ketamine clinicians have specifically praised her expertise in this area. That is not a credential she markets. It is something her patients and her peers have observed directly.

Her physician supervisor, Dr. Rubin, a board-certified oncologist and Clinical Associate Professor at Drexel University College of Medicine, provides the physician oversight that serious clinical work demands. Staff member Tee completes a care team that patients consistently describe as warm, non-judgmental, and genuinely present, even during the most difficult sessions.

When you are dealing with PTSD, who is in the room with you matters. We take that seriously.

Frequently Asked Questions About PTSD Treatment in Lower Merion Township